Apremilast, beyond psoriasis as a therapeutic target

Med Clin (Barc). 2017 Jul 7;149(1):42-43. doi: 10.1016/j.medcli.2017.01.008. Epub 2017 Feb 24.

[Article in English, Spanish]

Authors

Ricardo Ruiz-Villaverde¹, Ahinoa Bueno-Rodriguez², Jesús Tercedor-Sánchez²

Affiliations

¹ Unidad de Dermatología, Complejo Hospitalario de Granada, Granada, España. Electronic address: ismenios@hotmail.com.
² Unidad de Dermatología, Complejo Hospitalario de Granada, Granada, España.

PMID: 28242122
DOI: 10.1016/j.medcli.2017.01.008

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adolescent
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
Female
Humans
Psoriasis / drug therapy*
Thalidomide / analogs & derivatives*
Thalidomide / therapeutic use

Substances

Anti-Inflammatory Agents, Non-Steroidal
Thalidomide
apremilast